Silverfin false false 31/12/2024 01/01/2024 31/12/2024 L Delamaine 19/11/2002 25 July 2025 no description of principal activity 04594476 2024-12-31 04594476 bus:Director1 2024-12-31 04594476 2023-12-31 04594476 core:CurrentFinancialInstruments 2024-12-31 04594476 core:CurrentFinancialInstruments 2023-12-31 04594476 core:Non-currentFinancialInstruments 2024-12-31 04594476 core:Non-currentFinancialInstruments 2023-12-31 04594476 core:ShareCapital 2024-12-31 04594476 core:ShareCapital 2023-12-31 04594476 core:SharePremium 2024-12-31 04594476 core:SharePremium 2023-12-31 04594476 core:RetainedEarningsAccumulatedLosses 2024-12-31 04594476 core:RetainedEarningsAccumulatedLosses 2023-12-31 04594476 core:LeaseholdImprovements 2023-12-31 04594476 core:PlantMachinery 2023-12-31 04594476 core:FurnitureFittings 2023-12-31 04594476 core:ComputerEquipment 2023-12-31 04594476 core:LeaseholdImprovements 2024-12-31 04594476 core:PlantMachinery 2024-12-31 04594476 core:FurnitureFittings 2024-12-31 04594476 core:ComputerEquipment 2024-12-31 04594476 2022-12-31 04594476 core:AcceleratedTaxDepreciationDeferredTax 2024-12-31 04594476 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 04594476 bus:OrdinaryShareClass1 2024-12-31 04594476 core:WithinOneYear 2024-12-31 04594476 core:WithinOneYear 2023-12-31 04594476 core:BetweenOneFiveYears 2024-12-31 04594476 core:BetweenOneFiveYears 2023-12-31 04594476 core:MoreThanFiveYears 2024-12-31 04594476 core:MoreThanFiveYears 2023-12-31 04594476 2024-01-01 2024-12-31 04594476 bus:FilletedAccounts 2024-01-01 2024-12-31 04594476 bus:SmallEntities 2024-01-01 2024-12-31 04594476 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 04594476 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04594476 bus:Director1 2024-01-01 2024-12-31 04594476 core:LeaseholdImprovements core:TopRangeValue 2024-01-01 2024-12-31 04594476 core:PlantMachinery core:TopRangeValue 2024-01-01 2024-12-31 04594476 core:FurnitureFittings 2024-01-01 2024-12-31 04594476 core:ComputerEquipment core:TopRangeValue 2024-01-01 2024-12-31 04594476 2023-01-01 2023-12-31 04594476 core:LeaseholdImprovements 2024-01-01 2024-12-31 04594476 core:PlantMachinery 2024-01-01 2024-12-31 04594476 core:ComputerEquipment 2024-01-01 2024-12-31 04594476 core:CurrentFinancialInstruments 2024-01-01 2024-12-31 04594476 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 04594476 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 04594476 (England and Wales)

PERSONA COSMETIC MEDICINE LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2024
Pages for filing with the registrar

PERSONA COSMETIC MEDICINE LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2024

Contents

PERSONA COSMETIC MEDICINE LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2024
PERSONA COSMETIC MEDICINE LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2024
Director L Delamaine
Registered office 2nd Floor
Maritime Place Quayside
Chatham Maritime
ME4 4QZ
Kent
United Kingdom
Company number 04594476 (England and Wales)
Chartered accountants Kreston Reeves LLP
2nd Floor, Maritime Place
Quayside
Chatham Maritime
Chatham, Kent
ME4 4QZ

ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF PERSONA COSMETIC MEDICINE LIMITED

For the financial year ended 31 December 2024

ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF PERSONA COSMETIC MEDICINE LIMITED (continued)

For the financial year ended 31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Persona Cosmetic Medicine Limited for the financial year ended 31 December 2024 which comprise the Balance Sheet and the related notes 1 to 10 from the Company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/regulation.

It is your duty to ensure that Persona Cosmetic Medicine Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Persona Cosmetic Medicine Limited. You consider that Persona Cosmetic Medicine Limited is exempt from the statutory audit requirement for the financial year.

We have not been instructed to carry out an audit or a review of the financial statements of Persona Cosmetic Medicine Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

This report is made solely to the Director of Persona Cosmetic Medicine Limited, as a body, in accordance with the terms of our engagement letter dated 09 August 2023. Our work has been undertaken solely to prepare for your approval the financial statements of Persona Cosmetic Medicine Limited and state those matters that we have agreed to state to the director of Persona Cosmetic Medicine Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Persona Cosmetic Medicine Limited and its Director as a body for our work or for this report.

Kreston Reeves LLP
Chartered Accountants

2nd Floor, Maritime Place
Quayside
Chatham Maritime
Chatham, Kent
ME4 4QZ

25 July 2025

PERSONA COSMETIC MEDICINE LIMITED

BALANCE SHEET

As at 31 December 2024
PERSONA COSMETIC MEDICINE LIMITED

BALANCE SHEET (continued)

As at 31 December 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 79,422 93,359
79,422 93,359
Current assets
Stocks 7,235 6,168
Debtors 4 206,229 200,313
Cash at bank and in hand 482 300
213,946 206,781
Creditors: amounts falling due within one year 5 ( 190,099) ( 162,838)
Net current assets 23,847 43,943
Total assets less current liabilities 103,269 137,302
Creditors: amounts falling due after more than one year 6 ( 71,517) ( 119,288)
Provision for liabilities 7 ( 9,306) ( 12,302)
Net assets 22,446 5,712
Capital and reserves
Called-up share capital 8 200 200
Share premium account 4,995 4,995
Profit and loss account 17,251 517
Total shareholders' funds 22,446 5,712

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Persona Cosmetic Medicine Limited (registered number: 04594476) were approved and authorised for issue by the Director on 25 July 2025. They were signed on its behalf by:

L Delamaine
Director
PERSONA COSMETIC MEDICINE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
PERSONA COSMETIC MEDICINE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Persona Cosmetic Medicine Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2nd Floor, Maritime Place Quayside, Chatham Maritime, ME4 4QZ, Kent, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements 10 years straight line
Plant and machinery 5 years straight line
Fixtures and fittings 25 % reducing balance
Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Borrowing costs

Borrowing costs that are directly attributable to acquisition, construction or production of qualifying assets, are capitalised as part of the cost of those assets. Capitalisation begins when both finance costs and expenditures for the asset are being incurred and activities that are necessary to get the asset ready for use are in progress. Capitalisation ceases when substantially all the activities that are necessary to get the asset ready for use are complete.

All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Statement of Income and Retained Earnings over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a financing transaction it is measured at X.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 9 9

3. Tangible assets

Leasehold improve-
ments
Plant and machinery Fixtures and fittings Computer equipment Total
£ £ £ £ £
Cost
At 01 January 2024 121,499 170,501 48,756 14,854 355,610
At 31 December 2024 121,499 170,501 48,756 14,854 355,610
Accumulated depreciation
At 01 January 2024 45,008 169,207 33,999 14,037 262,251
Charge for the financial year 8,999 434 3,687 817 13,937
At 31 December 2024 54,007 169,641 37,686 14,854 276,188
Net book value
At 31 December 2024 67,492 860 11,070 0 79,422
At 31 December 2023 76,491 1,294 14,757 817 93,359
Leased assets included above:
Net book value
At 31 December 2024 13,545 0 0 0 13,545
At 31 December 2023 15,350 0 0 0 15,350

4. Debtors

2024 2023
£ £
Other debtors 206,229 200,313

5. Creditors: amounts falling due within one year

2024 2023
£ £
Bank loans and overdrafts 67,796 68,682
Trade creditors 22,289 22,729
Taxation and social security 76,949 44,935
Obligations under finance leases and hire purchase contracts 3,676 2,906
Other creditors 19,389 23,586
190,099 162,838

Within bank overdrafts and loans are amounts of £24,502 (2023: £23,758) which are secured by way of a fixed and floating charge over the assets of the company.

6. Creditors: amounts falling due after more than one year

2024 2023
£ £
Bank loans 63,603 107,642
Obligations under finance leases and hire purchase contracts 7,914 11,646
71,517 119,288

7. Deferred tax

2024 2023
£ £
At the beginning of financial year ( 12,302) ( 12,002)
Credited/(charged) to the Statement of Income and Retained Earnings 2,996 ( 300)
At the end of financial year ( 9,306) ( 12,302)

The deferred taxation balance is made up as follows:

2024 2023
£ £
Accelerated capital allowances ( 9,306) ( 12,302)

8. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
200 Ordinary shares of £ 1.00 each 200 200

9. Financial commitments

Commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2024 2023
£ £
within one year 66,774 72,480
between one and five years 238,816 255,590
after five years 112,500 162,500
418,090 490,570

10. Related party transactions

Included within other debtors due within one year are loans to the directors. Interest was charged at the official rates of interest and added to the balance brought forward. The amount owed at 31 December 2024 was £131,287 (2023 - £125,371) which is repayable on demand.

During the year, the company paid dividends to directors who were also shareholders of the company totalling £98,985 (2023 - £79,671).

All other transactions with related parties that arose during the current and prior years, including directors' remuneration payable, were done so under normal market conditions.